<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01097798</url>
  </required_header>
  <id_info>
    <org_study_id>LBB-ALI-01/09</org_study_id>
    <nct_id>NCT01097798</nct_id>
  </id_info>
  <brief_title>To Evaluate the Efficacy and Safety Aliviador Compared to Gelol in Patients With Contusions, Sprains, Trauma and Muscle Injury.</brief_title>
  <acronym>LBB-ALI-01/09</acronym>
  <official_title>Multicenter, Randomized, Double-blind Trial to Evaluate the Efficacy and Safety Aliviador Compared to Gelol in the Relief in Patients With Contusons, Sprains,Trauma and Muscle Injury.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratorio Brasileiro de Biologia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratorio Brasileiro de Biologia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multicenter, randomized, double-blind trial, to evaluate the efficacy and safety Aliviador
      compared to Gelol in the relief of signs and symptoms in patients with contusions, sprains,
      trauma and muscle injury start with less than 24 hours or patients of myalgia, myofascial
      pain and tendinitis.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">August 2010</completion_date>
  <primary_completion_date type="Anticipated">August 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the efficacy in reducing signs and symptoms Aliviador compared to Gelol.</measure>
    <time_frame>two days</time_frame>
    <description>To evaluate the efficacy in reducing signs and symptoms Aliviador compared to Gelol in patients with contusions, sprains, muscle injury and trauma, starting less than 24 hours or patients with muscle pain, myofascial pain and tendinitis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate the tolerability use Aliviador compared to Gelol.</measure>
    <time_frame>two days</time_frame>
    <description>To evaluete the tolerability use Aliviador compared to Gelol in patients with contusions, sprains, muscle injury and traumas starting less than 24 hours or patients with myalgia, myofascial pain and tendinitis.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Contusions</condition>
  <condition>Sprains</condition>
  <condition>Trauma</condition>
  <condition>Muscle Injury</condition>
  <condition>Myalgia</condition>
  <condition>Myofascial Pain</condition>
  <condition>Tendinitis</condition>
  <arm_group>
    <arm_group_label>Aliviador</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Gelol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aliviador</intervention_name>
    <description>The study medication should be applied regimen of 8/8 hours over 2 days.</description>
    <arm_group_label>Aliviador</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gelol</intervention_name>
    <description>The study medication should be applied regimen of 8/8 hours over 2 days.</description>
    <arm_group_label>Gelol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of both sexes, of any race, aged over 12 years.

          -  Ability to read, understand and sign the IC, in the case of minors consent of
             responsible;

          -  Clinical diagnosis of bruises, sprains, trauma, muscle damage occurred in less than 24
             hours or muscle pain, myofascial pain or tendinitis.

          -  Patients able to understand and maintain the clinical protocol.

        Exclusion Criteria:

          -  Known hypersensitivity to components of the formulas of both the drug test as the
             comparator.

          -  Known hypersensitivity to paracetamol.

          -  Location of the lesion with skin wound or irritated.

          -  Liver or kidney disease known.

          -  Pregnant or lactating women.

          -  Patients who require surgery or immobilization.

          -  Patients with fractures or rupture of the ligaments.

          -  Patients using anticoagulants.

          -  Patients with severe concomitant systemic diseases, such as cancer, diabetes, or
             acquired heart disease, hematological diseases, seizure disorders, autoimmune
             diseases, renal failure, severe infections, hormonal disorders and pulmonary
             disorders.

          -  History of alcoholism or illicit drug use;

          -  Use of NSAIDs, corticosteroids or venoterápicos, topics or any other form of
             administration.

          -  Conditions in the opinion of the researcher make the patient unsuitable to participate
             in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abel Pereira Junior, investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculdade de Medicina do ABC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gilberto de Castro Brandão, investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clínica Perdizes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paulo Faria, investigator</last_name>
    <role>Principal Investigator</role>
    <affiliation>S.C. Corinthians Paulista</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Abel Pereira Junior, investigator principal</last_name>
    <phone>55 11 49905244</phone>
    <email>abelpsjr@terra.com.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Selma Squassoni, study coordinator</last_name>
    <phone>55 11 49935459</phone>
    <email>selma_denis@yahoo.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Faculdade de Medicina do ABC</name>
      <address>
        <city>Santo André</city>
        <state>São Paulo</state>
        <zip>09060-650</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Abel Pereira Junior, investigator</last_name>
      <phone>55 11 49905244</phone>
      <email>abelpsjr@terra.com.br</email>
    </contact>
    <contact_backup>
      <last_name>Selma Squassoni, study coordinator</last_name>
      <phone>55 11 49935459</phone>
      <email>selma_denis@yahoo.com.br</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Clínica Perdizes</name>
      <address>
        <city>São Paulo</city>
        <zip>05005-001</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gilberto de Castro Brandão, investigator</last_name>
      <phone>55 11 3825666</phone>
      <email>gilbertobrandao@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>S.C. Corinthians Paulista</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paulo de Faria</last_name>
      <phone>55 11 20953000</phone>
      <phone_ext>3146</phone_ext>
      <email>phfaria@uol.com.br</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2010</study_first_submitted>
  <study_first_submitted_qc>April 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2010</study_first_posted>
  <last_update_submitted>April 15, 2010</last_update_submitted>
  <last_update_submitted_qc>April 15, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 16, 2010</last_update_posted>
  <responsible_party>
    <name_title>Maria Lygia Bezerra</name_title>
    <organization>Laboratório Brasileiro de Biologia</organization>
  </responsible_party>
  <keyword>muscle injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Sprains and Strains</mesh_term>
    <mesh_term>Tendinopathy</mesh_term>
    <mesh_term>Myalgia</mesh_term>
    <mesh_term>Contusions</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

